Taken together, our findings suggest that the balance between IL-17 and IFNγ in Th17 cells, shaped by vitamin D3 signaling and OPN receptor engagement, may determine whether Th17 cells exert pro- or anti-tumor effects. This evidence concerns the gene IL17A and neoplasm.